Behavioral economics of drug self-administration and drug abuse policy.
Behavioral economics gives BCBAs a price tag for drug reinforcers and a map for policy-level fixes.
01Research in Context
What this study did
Bauman (1991) wrote a theory paper. It says we should use behavioral-economics ideas to study drug use.
The paper lists rules like price, amount, and delay. These rules change how much a drug is worth to the user.
The goal is to guide future studies and public laws, not to test one treatment.
What they found
The paper finds that drug taking is shopping. People buy highs the same way they buy snacks.
If the price goes up, use drops. If the high comes faster, value rises. These facts can shape city and clinic rules.
How this fits with other research
Trusty et al. (2021) extends the same rules to depression. They say sunk-cost and default bias keep adults from seeking help. Both papers use price, effort, and delay to explain choices.
Eagle (1985) came first. It also asked behavior analysts to wed economics, but it looked at big markets, not drug abuse. Bauman (1991) narrows the lens to one public-health problem.
Fraley (1998) nods to the plan. It says behavior analysts already own the tools—choice, rules, equivalence—to study decisions. Bauman (1991) adds the price tag.
Why it matters
You can plug these price rules into your intake today. Ask: What is the client paying in time, money, or social risk to get the drug? Raise that cost or drop the reward delay for clean behavior. City teams can do the same: tax, limit hours, add wait time. The paper gives you a ready ruler for both clinic and policy work.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →List every cost your client pays to stay clean—bus fare, pharmacy line, stigma—then cut one cost this week.
02At a glance
03Original abstract
The concepts of behavioral economics have proven useful for understanding the environmental control of overall levels of responding for a variety of commodities, including reinforcement by drug self-administration. These general concepts are summarized for application to the analysis of drug-reinforced behavior and proposed as the basis for future applications. This behavioral agenda includes the assessment of abuse liability, the assay of drug-reinforcer interactions, the design of drug abuse interventions, and the formulation of drug abuse public policy. These separate domains of investigation are described as part of an overall strategy for designing model projects to control drug use and testing public policy initiatives.
Journal of the experimental analysis of behavior, 1991 · doi:10.1901/jeab.1991.56-377